API Intermediates
Pharmaceutical Intermediates is part of Pharmaceutical Ingredients group. Corey Organics meet the highest standards of quality to comply with regulations. Corey Organics supply Pharmaceutical Intermediates globally to countries such as United States, Europe, China, Japan, Germany, Switzerland, Dubai, Australia, UK and many more.
Olanzapine intermediates
| Intermediates of Olanzapine |
CAS NO |
API |
QUOTE |
| 2-Amino-5-Methylthiophene-3-Carbonitrile |
138564-58-6 |
Olanzapine |
 |
| 2-(2-Nitroanilino)-5-methylthiophene-3-carbonitrile |
138564-59-7 |
Olanzapine |
|
| 4-Amino-2-Methyl10H-Theino-{2,3-b}[1,5]-bdz HCL |
138564-60-0 |
Olanzapine |
|
Iloperidone, Risperidone, Paliperidone intermediates
| Intermediates of Iloperidone, Risperidone, Paliperidone |
CAS NO |
API |
QUOTE |
| (2, 4-dp)-piperidin-4-yl-methanone oxime Hcl |
135634-18-3 |
Iloperidone, Risperidone, Paliperidone |
|
| 6-Fluoro-3-(4-Piperidinyl)-1,2-Benzisoxazole |
84163-77-9 |
Iloperidone, Risperidone, Paliperidone |
|
| 6-Fluoro-3-(4-Piperidinyl)-1,2-Benzisoxazole HCL |
84163-13-3 |
Iloperidone, Risperidone, Paliperidone |
|
| 3-(2-CE)-2-M-6,7,8,9-th-4H-pyrido[1,2-a]P-4-one Hcl (SC) |
93076-03-0 |
Iloperidone, Risperidone, Paliperidone |
|
Irbesartan, Sparsentan intermediates
| Intermediates of Irbesartan, Sparsentan |
CAS NO |
API |
QUOTE |
| 2-Butyl-1,3-Diazaspiro [4,4] non-1-en-4-One Hcl (Spiro) |
151257-01-1 |
Irbesartan, Sparsentan |
|
| Cyano Irbesartan |
138401-24-8 |
Irbesartan, Sparsentan |
|
| 2-Butyl-1,3-diaza-spiro[4.4]non-1-en-4-one |
138402-05-8 |
Irbesartan, Sparsentan |
|
Bedaquiline intermediates
| Intermediates of Bedaquiline |
CAS NO |
API |
QUOTE |
| N-(4-Bromo Phenyl)-3-Phenyl Propenamide |
316146-27-7 |
Bedaquiline |
|
| 3-Benzyl-6-Bromo-2-Chloro Quinoline |
654655-68-2 |
Bedaquiline |
|
| 3-Benzyl-6-Bromo-2-Methoxy Quinoline |
654655-69-3 |
Bedaquiline |
|
| 3-(Dimlamino)-1-(Naphthalen-1-yl) Propan-1-one Hcl (SC) |
5409-58-5 |
Bedaquiline |
|
Flibanserin intermediates
| Intermediates of Flibanserin |
CAS NO |
API |
QUOTE |
| 1-(Prop-1en-2yl)-1H-Benzo (d)-Imidazol-2-(3H)-one |
52099-72-6 |
Flibanserin |
|
| 1-(2-BE)-3-(Prop-1-en-2yl)-1H-Benzo(d)-Imidzol-2-(3H)-one |
136081-17-9 |
Flibanserin |
|
| 1-(Prp-1-en-2yl)-3-(2-(4-3-Tm)P)P-1yl)etl)-1h-B(d)-Im-2-3h-1 |
1971858-36-2 |
Flibanserin |
|
| 1-(2-(4-(3-(Tl)l)Pirzin-1yl)-etyl)-1H-bnz(d)Im-2-(3H)-one HCl |
147359-76-0 |
Flibanserin |
|
Lucanthone intermediates
| Intermediates of Lucanthone |
CAS NO |
API |
QUOTE |
| Ethyl 2,4-Dihydroxy-6-methylnicotinate |
70254-52-3 |
Lucanthone |
|
| 3-Dimethylamino-1-propyl chloride hydrochloride |
5407-04-5 |
Lucanthone |
|
| 1-Bromo-2-butyne |
3355-28-0 |
Lucanthone |
|
Ebastine
| Intermediates of Ebastine |
CAS NO |
API |
QUOTE |
| 4-(Benz Hydryloxy) Piperidine |
58258-01-8 |
Ebastine |
|
| 4′-tert-Butyl-4-chlorobutyrophenone |
43076-61-5 |
Ebastine |
|
| 4-Diphenylmethoxypiperidine hydrochloride |
65214-86-0 |
Ebastine |
|
Tizanidine
| Intermediates of Tizanidine |
CAS NO |
API |
QUOTE |
| 4-Chloro-O-Phenylene diamine |
95-83-0 |
Tizanidine |
|
| 5-Chloro-2,1,3-Benzothiadiazole |
2207-32-1 |
Tizanidine |
|
| 4-Nitro-5-Chloro-2,1,3-Benzothiadiazole |
2274-89-7 |
Tizanidine |
|
| 4-Amino-5-chloro-2,1,3-Benzothiadiazole |
30536-19-7 |
Tizanidine |
|
| N-5-Chloro-2,1,3-Benzothiadiazole-4yl) Thiourea |
51323-05-8 |
Tizanidine |
|
Zonisamide, Warfarin
| Intermediates of Zonisamide, Warfarin |
CAS NO |
API |
QUOTE |
| 4-Hydroxy Coumarin |
1076-38-6 |
Zonisamide, Warfarin |
|
Asciminib
| Intermediates of Asciminib |
CAS NO |
API |
QUOTE |
| 5-Bromo-6-Chloro nicotinic acid |
29241-62-1 |
Asciminib |
|
| 5-Bromo-6-Hydroxy nicotinic acid |
41668-13-7 |
Asciminib |
|
| 5-Chloro-6- Hydroxy nicotinic acid |
54127-63-8 |
Asciminib |
|
Vortioxetine
| Intermediates of Vortioxetine |
CAS NO |
API |
QUOTE |
| 2-(4-Benzyl piperazin-1yl)-Aniline |
199105-17-4 |
Vortioxetine |
|
| 1-(4-(tert-butyl) phenyl)-4-chlorobutan-1-one (4’T-B-4-CBP) |
43076-61-5 |
Vortioxetine |
|
| 1-(2-Nitrophenyl)-piperazine |
59084-06-09 |
Vortioxetine |
|
Mirabegron
| Intermediates of Mirabegron |
CAS NO |
API |
QUOTE |
| 2-(4-Nitrophenyl) ethylamine Hydrochloride |
29968-78-3 |
Mirabegron |
|
Selpercatinib
| Intermediates of Selpercatinib |
CAS NO |
API |
QUOTE |
| 4-Nitro Benzene Sulfonyl Chloride |
93-74-8 |
Selpercatinib |
|
Trilaciclib
| Intermediates of Trilaciclib |
CAS NO |
API |
QUOTE |
| 1-Methyl-4-(6-nitropyridin-3-yl) piperazine |
657410-79-2 |
Trilaciclib |
|
| 5-(4-Methylpiperazin-1-yl) pyridin-2-amine |
571189-49-6 |
Trilaciclib |
|
Dabigatran
| Intermediates of Dabigatran |
CAS NO |
API |
QUOTE |
| Ethyl-3-(Pyridin-2yl-Amino) propionate |
103041-38-9 |
Dabigatran |
|
| 3-[(3-A-4-MAB pyridine-2-ylamino]propionic acid ethyl ester |
212322-56-0 |
Dabigatran |
|
| E-3-(2-C M)-1-M-N-(Py-2yl)-1H-B(d)-Imi-5-C- Propanoate |
1307233-94-8 |
Dabigatran |
|
| 4-Amino Benzonitrile |
873-74-5 |
Dabigatran |
|
| 4-Cyano phenyl Glycine |
42288-26-6 |
Dabigatran |
|
| 4-Amino-N-Hydroxy Benzimidamide |
277319-62-7 |
Dabigatran |
|
| Hexyl Amino-4-amino phenyl methylene carbamate HCL |
1307233-93-7 |
Dabigatran |
|
Etoricoxib
| Intermediates of Etoricoxib |
CAS NO |
API |
QUOTE |
| 1,4-methylsulfonile Phenyl Ethanone |
10297-73-1 |
Etoricoxib |
|
| 4-Methyl Sulfonyl Phenyl acetic acid |
90536-66-6 |
Etoricoxib |
|
| Ketosulfone |
221615-75-4 |
Etoricoxib |
|
| 4-(Methylthio) Phenyl acetic acid |
16188-55-9 |
Etoricoxib |
|
| 3-[2-(4(Methylthio)phenyl)-2cyano-acetyl]-(6Methyl)pyridine |
321913-54-6 |
Etoricoxib |
|
| 1-(6-Methyl Pyridin-3yl)-2-(4-Methyl thio) Phenyl ethenone |
221615-72-1 |
Etoricoxib |
|
| 2-Chloro-1,3bis(dma)t hexafluorophosphate (Side Chain) |
249561-98-6 |
Etoricoxib |
|
Vardenafil
| Intermediates of Vardenafil |
CAS NO |
API |
QUOTE |
| 2-Ethoxy Benzamide |
938-73-8 |
Vardenafil |
|
| 2-Butyryl amino Propionic acid (Side Chain) |
59875-04-6 |
Vardenafil |
|
Dpenicillamine
| Intermediates of Dpenicillamine |
CAS NO |
API |
QUOTE |
| 2-Isopropyl-5,5-DimethylThiazolidine-4-CarboNitrile |
13206-50-3 |
Dpenicillamine |
|
| 2-Isopropyl-5,5-DimethylThiazolidine-4-Carboxylic Acid Hcl |
13385-66-5 |
Dpenicillamine |
|
Dapagliflozin
| Intermediates of Dapagliflozin |
CAS NO |
API |
QUOTE |
| 2-Chloro-5-Bromobenzoic acid |
21739-92-4 |
Dapagliflozin |
|
Bilastine
| Intermediates of Bilastine |
CAS NO |
API |
QUOTE |
| 2-(Piperidin-4-YL)-1H-benzo[D]imidazole |
38385-95-4 |
Bilastine |
|
| tert-Butyl 4-(1H-benzo[d]imidazol-2-yl) piper-1-carboxylate |
953071-73-3 |
Bilastine |
|
| tert-Butyl 4-(1-(2-eel)-1H-b[d]imd-2yl)pip-1-carboxylate |
1181267-36-6 |
Bilastine |
|
| 1-(2-Eethyl)-2-(Pip-4-yl)-1H-B(d) Imidazole Sesqui Hydrate |
110963-63-8 |
Bilastine |
|
| Methyl-2-(4-(2-Chloroethylphenyl)-2-Me Propanoate (SC) |
1181267-33-3 |
Bilastine |
|
Bendamustine
| Intermediates of Bendamustine |
CAS NO |
API |
QUOTE |
| N-Methyl-2,4-dinitroaniline |
2044-88-4 |
Bendamustine |
|
| N1-Methyl-4-nitrobenzene-1,2-diamine |
41939-61-1 |
Bendamustine |
|
| 3-(1-methyl-5-N-1H-Benzo(D)Imidazole-2-Yl)Propionic acid |
3543-72-4 |
Bendamustine |
|
| 1-Methyl-5-N-1H-benzimidazole-2-butanoic acid ethyl ester |
|
Bendamustine |
|
Raltegravir
| Intermediates of Raltegravir |
CAS NO |
API |
QUOTE |
| M 2-(2-(((B)C)A)P-2-yl)-5-H-6-oxo-1,6-DHP-4-C |
519032-08-7 |
Raltegravir |
|
| B[1-[4-[[(4-F)A]C]-5-H-1-M-6-oxo-1,6-DHP-2-yl]-1-ME]C |
518048-02-7 |
Raltegravir |
|
| 2-(2-AP-2-yl)-N-(4-FB)-5-H-1-M-6-oxo-1,6-DHP-4-C |
518048-03-8 |
Raltegravir |
|
| Potassium-5-methyl-1,3,4-oxadiazole-2-carboxylate |
888504-28-7 |
Raltegravir |
|
Perfenidone
| Intermediates of Perfenidone |
CAS NO |
API |
QUOTE |
| 2-HYDROXY-5-METHYLPYRIDINE |
1003-68-5 |
PIRFENIDONE |
|
Adapalene
| Intermediates of Adapalene |
CAS NO |
API |
QUOTE |
| 6-Bromo-2-Naphthoic Acid |
5773-80-8 |
Adapalene |
|
| Methyl-6-Bromo-2-Naphthoate |
33626-98-1 |
Adapalene |
|
Rasagiline
| Intermediates of Rasagiline |
CAS NO |
API |
QUOTE |
| 1-Aminoindane HCL |
70146-17-4 |
Rasagiline |
|
Zileuton
| Intermediates of Zileuton |
CAS NO |
API |
QUOTE |
| 2-Acetyl Benzothiophene |
22720-75-8 |
Zileuton |
|
Tazarotene
| Intermediates of Tazarotene |
CAS NO |
API |
QUOTE |
| 6-Chloro Nicotinic Acid EE |
49608-01-7 |
Tazarotene |
|
| 6-Chloro Nicotinic Acid ME |
73781-91-6 |
Tazarotene |
|
Lapatinib
| Intermediates of Lapatinib |
CAS NO |
API |
QUOTE |
| 2-Amino Benzonitrile |
1885-29-6 |
Lapatinib |
|
Dilitiazem
| Intermediates of Dilitiazem |
CAS NO |
API |
QUOTE |
| 2-Amino Thiophenol |
137-07-5 |
Dilitiazem |
|
Rilapladib
| Intermediates of Rilapladib |
CAS NO |
API |
QUOTE |
| 4-Bromo Benzonitrile |
623-00-7 |
Rilapladib |
|
Bexagliflozin
| Intermediates of Bexagliflozin |
CAS NO |
API |
QUOTE |
| 5-Bromo-2-Chlorobenzoic Acid |
21739-92-4 |
Bexagliflozin |
|
Vonoprozone
| Intermediates of Vonoprozone |
CAS NO |
API |
QUOTE |
| Pyridine-3-Sulfonic Acid |
636-73-7 |
Vonoprozone |
|
Avatrombopag Maleate
| Intermediates of Avatrombopag Maleate |
CAS NO |
API |
QUOTE |
| 5,6-Dichloro Nicotinic Acid |
41667-95-2 |
Avatrombopag Maleate |
|
Befetupitant
| Intermediates of Befetupitant |
CAS NO |
API |
QUOTE |
| 6-Chloro Nicotinic Acid |
5326-23-8 |
Befetupitant |
|
| 6-Hydroxy Nicotinic Acid |
5006-66-6 |
Befetupitant |
|
Donafenib
| Intermediates of Donafenib |
CAS NO |
API |
QUOTE |
| 4-Chloropyridine-2-Carboxylic Acid ME |
24484-93-3 |
Donafenib |
|
Cariprazine HCL
| Intermediates of Cariprazine HCL |
CAS NO |
API |
QUOTE |
| Ethyl-2-((1R,4R-4-Amino Cyclohexyl) acetate HCL |
76308-26-4 |
Cariprazine HCL |
|
| Tert butyl (1R,4R-4-(2-Hydroxy ethyl) Cyclohexyl carbamate |
917342-29-1 |
Cariprazine HCL |
|
| Trans-2-(1-(4-(N-tert butoxy carbonyl)-1amino)-cyclohexyl) ethanol |
215790-29-7 |
Cariprazine HCL |
|
| Trans-4-(2-(4-(2,3-DIC P)-Piperazin-1yl) E cyclohexyl)-1,1-DiM EE |
506427-91-4 |
Cariprazine HCL |
|
| Trans-4-(2(2,3-DiC P)-1-Piperazinyl) ethyl-Cyclohexyl amine MH |
791778-53-5 |
Cariprazine HCL |
|
| Trans-N-(4-(2-(4-(2,3-DiC P) Piperazin-1yl) E) cyclohexyl) N,N-DiM urea |
839712-12-8 |
Cariprazine HCL |
|
